CDS LTX CONTROL LATEX PARTICLE SUSPENSION AND PRIMER— 510(k) K993375

Substantially Equivalent

Clinical Diagnostic Solutions, Inc.

FDA 510(k) clearance K993375 for CDS LTX CONTROL LATEX PARTICLE SUSPENSION AND PRIMER, Substantially Equivalent on 1999-12-20. Applicant: Clinical Diagnostic Solutions, Inc..

Clearance details

Applicant: Clinical Diagnostic Solutions, Inc.
Product code: Code KRX
Advisory panel: Hematology
Date received: 1999-10-07
Decision date: 1999-12-20
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Plantation, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.